IBM ELA Review and Optimization for a French Global Professional Services Company

The Challenge

A multinational professional services group with significant operations across North America, Europe, and Asia-Pacific was approaching renewal of its IBM Enterprise License Agreement, which covered middleware (WebSphere, MQ), databases (DB2, Informix), and mainframe infrastructure supporting core operations across consulting delivery, legal case management, and financial processing systems. The existing three-year ELA, executed in 2023, contained standard annual price escalation clauses and had been structured without a comprehensive audit of actual sub-capacity usage patterns or ILMT compliance metrics.

The organisation faced multiple headwinds on the renewal. First, IBM's standard list price increases on enterprise software ranged from 4.5% to 6.2% annually depending on product category. Second, the legacy ELA included embedded annual uplift clauses of 4.5% per annum. Third, and most significantly, the IT organisation suspected that the ELA included significant over-provisioning of sub-capacity licenses across its virtualised infrastructure — particularly in lower-utilisation environments serving non-critical applications in smaller jurisdictions — but lacked independent verification of the actual licensable capacity in use.

The CFO's mandate was explicit: the organisation needed to reduce its annual IBM ELA spend by at least 20% at renewal or face escalating software costs that would consume an additional €8-12M over the three-year renewal period. Achieving that outcome required moving beyond a straightforward price negotiation into a comprehensive cost optimisation programme.

The Approach

Redress Compliance was engaged eighteen months before the ELA renewal to lead a multi-phase IBM licensing optimization and contract renegotiation programme. The engagement proceeded through four structured phases.

Phase 1: Comprehensive IBM Software Estate Audit and Capacity Mapping

An independent audit of the organisation's entire IBM software footprint was conducted, spanning all geographic regions, business units, and technology environments. The audit used both IBM's native reporting tools and independent ILMT analysis to establish a definitive baseline of licensable processor capacity in active use across all virtualised infrastructure, database instances, and middleware deployments.

The audit revealed that approximately 28% of the organisation's provisioned sub-capacity across its virtualised environments was allocated to non-critical or legacy applications with minimal active workloads. Additionally, the audit identified 14 virtualised clusters in smaller European and APAC jurisdictions running at average processor utilisation below 12%, yet licensed for their full provisioned capacity. This analysis formed the basis for proposing a right-sized capacity baseline for the renewal ELA.

Phase 2: Sub-Capacity Optimization and ILMT Compliance Remediation

Working with the IT operations team, Redress designed a sub-capacity optimization programme that involved rightsizing virtual machine CPU allocations to align with actual peak demand plus a 15% operational headroom buffer. Rather than licensing the entire hypervisor cluster, the programme implemented granular CPU limits on individual VMs, reducing the total licensable capacity footprint by 24% without impacting application performance or business continuity.

In parallel, a comprehensive ILMT compliance remediation was undertaken. The legacy ILMT installation had not been updated in eighteen months, and several critical deployments were not reporting usage data to the central repository. Following remediation, the organisation achieved continuous, real-time ILMT reporting across 100% of its IBM software estate, improving compliance visibility and enabling ongoing capacity optimisation throughout the new ELA term.

Phase 3: Benchmark Analysis and Contract Restructuring

Independent benchmarking of IBM sub-capacity rates for equivalent enterprise professional services buyers confirmed that the organisation's existing per-unit rates were approximately 16% above market median for transactions of equivalent scale and commitment term. Additionally, analysis of the legacy ELA's annual uplift clause revealed that over the three-year original term, the 4.5% annual escalation was compounding to a 14.2% total cost increase — substantially above both IBM's list price increases and typical market inflation.

The renegotiation strategy targeted: (1) elimination of the multi-year uplift clause in favour of annual price caps at 2% per annum, (2) per-unit rate reductions of 18-22% on core middleware products aligned with the benchmarking data, and (3) consolidation of disparate licensing models (sub-capacity, MSU, and hybrid licensing in legacy contracts) into a unified single ELA structure with simplified commercial terms.

Phase 4: Final Negotiation and Three-Year ELA Close

IBM negotiations proceeded over twelve weeks of structured commercial discussions. The combination of reduced license counts from the sub-capacity optimization programme, strong benchmarking data demonstrating pricing gaps, and the threat of potential workload migration to alternative platforms (including containerised environments using Cloud Pak licensing models) proved effective. The final ELA delivered a 31% reduction in annual costs compared to the organisation's existing contract baseline, translating to €9.8M in total savings over the three-year term.

The Outcome

Key Takeaways

• Sub-capacity over-provisioning is the hidden cost driver in IBM ELAs. Most organisations license hypervisor cluster capacity without analysing actual per-VM utilisation. Granular CPU allocation analysis consistently reveals 15-30% excess capacity that can be eliminated at renewal — but only with independent ILMT data as the negotiation baseline.
• ILMT compliance gaps obscure true license usage patterns. Organisations with incomplete ILMT reporting across their estates have no visibility into actual processor utilisation, and therefore no factual basis for negotiating reduced license counts. Full compliance requires proactive remediation and ongoing monitoring.
• Annual uplift clauses compound to substantial cost escalations. A 4.5% annual escalation clause over three years increases total contract cost by 14.2% above the base year — far exceeding IBM's actual list price increases. Negotiating this to 0-2% is a consistently high-value outcome in IBM ELA renewals.
• Mainframe MIPS and sub-capacity optimisation require specialist expertise. The interaction between MSU-based licensing on mainframes, sub-capacity licensing on virtual systems, and capacity planning across hybrid environments requires deep technical and commercial expertise — and independent analysis is critical to avoiding compliance risks or overpayment.
• Unified ELA structures reduce complexity and improve flexibility. Consolidating separate licensing models into a single ELA simplifies compliance administration, improves transparency of total IBM software spend, and creates commercial leverage for rate negotiations across the entire portfolio.